BR0213299A - Utilização de cistationina - Google Patents

Utilização de cistationina

Info

Publication number
BR0213299A
BR0213299A BR0213299-0A BR0213299A BR0213299A BR 0213299 A BR0213299 A BR 0213299A BR 0213299 A BR0213299 A BR 0213299A BR 0213299 A BR0213299 A BR 0213299A
Authority
BR
Brazil
Prior art keywords
cystathionine
composition
cystationin
relates
present
Prior art date
Application number
BR0213299-0A
Other languages
English (en)
Inventor
Paul-Andre Finot
Tuong Huynh-Ba
Jacques Vuichoud
Denis Breuille
Original Assignee
Nestle Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nestle Sa filed Critical Nestle Sa
Publication of BR0213299A publication Critical patent/BR0213299A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/175—Amino acids
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/06—Anabolic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Food Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Polymers & Plastics (AREA)
  • Nutrition Science (AREA)
  • Mycology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Neurology (AREA)
  • Toxicology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Biochemistry (AREA)
  • Communicable Diseases (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pulmonology (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Fodder In General (AREA)
  • Dairy Products (AREA)

Abstract

"UTILIZAçãO DE CISTATIONINA". A presente invenção refere-se à utilização de cistationina em uma composição nutricional, um suplemento alimentar, uma composição profilática, ou uma fórmula infantil.
BR0213299-0A 2001-10-16 2002-10-08 Utilização de cistationina BR0213299A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP01203902A EP1302115A1 (fr) 2001-10-16 2001-10-16 Utilisation de cystathionine
PCT/EP2002/011266 WO2003032753A1 (fr) 2001-10-16 2002-10-08 Utilisation de cystathionine

Publications (1)

Publication Number Publication Date
BR0213299A true BR0213299A (pt) 2004-10-26

Family

ID=8181067

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0213299-0A BR0213299A (pt) 2001-10-16 2002-10-08 Utilização de cistationina

Country Status (13)

Country Link
US (1) US20050064014A1 (pt)
EP (2) EP1302115A1 (pt)
JP (1) JP2005505599A (pt)
CN (1) CN1571637A (pt)
BR (1) BR0213299A (pt)
CA (1) CA2461758A1 (pt)
CO (1) CO5580729A2 (pt)
MX (1) MXPA04003499A (pt)
NO (1) NO20041968L (pt)
PL (1) PL368321A1 (pt)
RU (1) RU2004114844A (pt)
WO (1) WO2003032753A1 (pt)
ZA (1) ZA200403687B (pt)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2886154B1 (fr) * 2005-05-27 2010-03-26 Cothera Composition pour retarder le developpement de la maladie d'alzheimer
CA2620313C (en) * 2005-06-14 2011-08-02 Nestec S.A. Nutritional method for elderly people
EP2044851A1 (en) * 2007-09-26 2009-04-08 Nestec S.A. Prevention of allergy at weaning
KR101519654B1 (ko) * 2008-10-02 2015-05-18 (주)아모레퍼시픽 슬리밍용 조성물
FR2966040A1 (fr) * 2010-10-19 2012-04-20 Brigitte Gourlaouen Composition amincissante et/ou de prevention des processus inflammatoires
WO2012167092A2 (en) * 2011-06-03 2012-12-06 The Regents Of The University Of Colorado, A Body Corporate Uses of and methods of treatment with cystathionine
US8183227B1 (en) 2011-07-07 2012-05-22 Chemo S. A. France Compositions, kits and methods for nutrition supplementation
US8168611B1 (en) 2011-09-29 2012-05-01 Chemo S.A. France Compositions, kits and methods for nutrition supplementation
CA2915793A1 (en) * 2012-07-03 2014-01-09 Jay Pravda Methods for treating, diagnosing and/or monitoring progression of oxo associated states
WO2015178762A1 (en) * 2014-05-19 2015-11-26 N.V. Nutricia Enteral formulations for preterm infants comprising optimised phenylalanine intake levels
US11596167B2 (en) 2014-05-19 2023-03-07 N.V. Nutricia Formulas comprising optimised amino acid profiles
RU2018115645A (ru) * 2015-09-28 2019-10-28 Нестек С.А. Дифференцированные по полу искусственные питательные композиции и содержащие их системы питания
CN108369223B (zh) * 2015-12-30 2021-07-06 雀巢产品有限公司 用于测定去脂体重的方法
US11382885B2 (en) 2017-06-07 2022-07-12 The Regents Of The University Of California Compositions for treating fungal and bacterial biofilms and methods of using the same

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4419345A (en) * 1981-07-20 1983-12-06 Kinetic Systems, Inc. Sleep-inducing pharmaceutical composition and method
US4419435A (en) * 1982-05-21 1983-12-06 Eastman Kodak Company Photographic products and processes employing 6-heterocyclylazo-3-pyridinol nondiffusible cyan dye-releasing compounds and precursors thereof
JPH0621062B2 (ja) * 1988-11-10 1994-03-23 陶陶酒製造株式会社 肝障害抑制剤
FR2711529B1 (fr) * 1993-10-28 1996-07-05 Clintec Nutrition Cy Composition à base d'acides aminés destinée au traitement d'une infection ou d'une agression engendrant une réaction inflammatoire, chez les animaux et chez l'homme.
JP2727431B2 (ja) * 1994-10-04 1998-03-11 陶陶酒製造株式会社 生体内ラジカル消去剤
AU721067B2 (en) * 1995-04-25 2000-06-22 Oridigm Corporation S-adenosyl methionine regulation of metabolic pathways and its use in diagnosis and therapy
JPH107553A (ja) * 1996-03-21 1998-01-13 Toutoushiyu Seizo Kk 生体内ラジカル消去剤及び抗潰瘍剤
US6495170B1 (en) * 2000-08-16 2002-12-17 N. V. Nutricia Method of increasing the presence of glutathione in cells

Also Published As

Publication number Publication date
CO5580729A2 (es) 2005-11-30
NO20041968L (no) 2004-05-11
EP1302115A1 (fr) 2003-04-16
JP2005505599A (ja) 2005-02-24
US20050064014A1 (en) 2005-03-24
MXPA04003499A (es) 2004-07-30
RU2004114844A (ru) 2005-10-27
ZA200403687B (en) 2005-05-13
PL368321A1 (en) 2005-03-21
EP1437945A1 (fr) 2004-07-21
CA2461758A1 (en) 2003-04-24
WO2003032753A1 (fr) 2003-04-24
CN1571637A (zh) 2005-01-26

Similar Documents

Publication Publication Date Title
DK1455585T3 (da) Spædbörnsnæringssammensætninger med foröget alfa-lactalbuminindhold
BR0213299A (pt) Utilização de cistationina
BRPI0507593A (pt) composições contendo cis-isÈmeros de um composto carotenóide e processo
HUP0204382A2 (hu) Javított gyermektápszer-készítmény és eljárás táplálásra és tolerancia fokozására
WO2002062751A1 (fr) Nouveaux derives de cystine et inhibiteurs de l'activation des facteurs inflammatoires
WO2007074135A3 (en) Infant immunological formula
IL166483A0 (en) Pharmaceutical compositions containing ciclesonideand an antihistamine
MXPA04001256A (es) Productos de combinacion de derivados de propanolamina aril substituidos con otros ingredientes activos y su uso.
BR0113866A (pt) Gatifloxacina penta-hdratada
BR0001914A (pt) Compostos flavorizantes
DE60200476D1 (de) Kreatin-salz mit nahrungs- und therapeutischer verwendung und dieses enthaltende zusammensetzungen
BR0213536A (pt) Formulações de xarope de ribavirina
AU2001281880A1 (en) Use of a formulation made of or containing at least one dissimilated milk serum
BRPI0010150B8 (pt) solução oral de prucalopride
BRPI0414496A (pt) fórmula infantil
RS20050429A (en) Combination medicament
JP2004508310A5 (pt)
BRPI0411638A (pt) produto alimentìcio e métodos de preparação de uma formulação
BR0210496A (pt) Caldo de carne em pó
MXPA03010921A (es) Uso de acetil l-carnitina en asociacion con biotina para tratamiento der pacientes con diabetes mellitus resistente a insulina tipo 2.
BRPI0415428A (pt) formulações terapêuticas
ATE296039T1 (de) Zutat für säuglingsmilchnahrung
UY27475A1 (es) Amidas de ácido piperazinciclohexanocarboxílico sustituidas y su utilización
GB0128071D0 (en) Medicament
AU2003275360A8 (en) Aqueous 2,6-diisopropylphenol pharmaceutical compositions

Legal Events

Date Code Title Description
B11A Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing
B11Y Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette]
B15K Others concerning applications: alteration of classification

Ipc: A23L 33/175 (2016.01), A23L 33/17 (2016.01)